{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:39:20Z","timestamp":1779165560070,"version":"3.51.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04483-w","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:25:55Z","timestamp":1764375955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Salivary metabolites for pancreatic cancer diagnosis: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Maryam","family":"Koopaie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahnaz","family":"Fatahzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajad","family":"Kolahdooz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"issue":"27","key":"4483_CR1","volume":"27","author":"J-X Hu","year":"2021","unstructured":"Hu J-X, Zhao C-F, Chen W-B, Liu Q-C, Li Q-W, Lin Y-Y, et al. Pancreatic cancer: a review of epidemiology, trend, and risk factors. World J Gastroenterol. 2021;27(27):4298.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"4483_CR2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","volume":"163","author":"LD Wood","year":"2022","unstructured":"Wood LD, Canto MI, Jaffee EM, Simeone DM. Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment. Gastroenterology. 2022;163(2):386-402. e381.","journal-title":"Gastroenterology"},{"issue":"3","key":"4483_CR3","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"4483_CR4","unstructured":"Institute NC: Cancer Stat Facts: Pancreatic Cancer. In.: National Cancer Institute; 2021."},{"issue":"11","key":"4483_CR5","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3390\/diagnostics10110869","volume":"10","author":"G Gheorghe","year":"2020","unstructured":"Gheorghe G, Bungau S, Ilie M, Behl T, Vesa CM, Brisc C, et al. Early diagnosis of pancreatic cancer: the key for survival. Diagnostics. 2020;10(11):869.","journal-title":"Diagnostics"},{"issue":"1","key":"4483_CR6","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2020-000408","volume":"7","author":"MN Yousaf","year":"2020","unstructured":"Yousaf MN, Chaudhary FS, Ehsan A, Suarez AL, Muniraj T, Jamidar P, et al. Endoscopic ultrasound (EUS) and the management of pancreatic cancer. BMJ Open Gastroenterol. 2020;7(1):e000408.","journal-title":"BMJ Open Gastroenterol"},{"key":"4483_CR7","volume":"96","author":"FN Al-Shaheri","year":"2021","unstructured":"Al-Shaheri FN, Alhamdani MS, Bauer AS, Giese N, B\u00fcchler MW, Hackert T, et al. Blood biomarkers for differential diagnosis and early detection of pancreatic cancer. Cancer Treat Rev. 2021;96:102193.","journal-title":"Cancer Treat Rev"},{"key":"4483_CR8","doi-asserted-by":"crossref","unstructured":"Boyd LN, Ali M, Leeflang MM, Treglia G, de Vries R, Le Large TY, Besselink MG, Giovannetti E, van Laarhoven HW, Kazemier G: Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: a meta-analysis of aggregate and individual participant data. EClinicalMedicine 2023; 55.","DOI":"10.1016\/j.eclinm.2022.101747"},{"issue":"7","key":"4483_CR9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.oraloncology.2012.01.021","volume":"48","author":"J Liu","year":"2012","unstructured":"Liu J, Duan Y. Saliva: a potential media for disease diagnostics and monitoring. Oral Oncol. 2012;48(7):569\u201377.","journal-title":"Oral Oncol"},{"key":"4483_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gm383","volume":"4","author":"NJ Bonne","year":"2012","unstructured":"Bonne NJ, Wong DT. Salivary biomarker development using genomic, proteomic and metabolomic approaches. Genome Med. 2012;4:1\u201312.","journal-title":"Genome Med"},{"issue":"7","key":"4483_CR11","doi-asserted-by":"crossref","DOI":"10.3390\/jpm13071039","volume":"13","author":"FL Martin","year":"2023","unstructured":"Martin FL, Dickinson AW, Saba T, Bongers T, Singh MN, Bury D. Atr-ftir spectroscopy with chemometrics for analysis of saliva samples obtained in a lung-cancer-screening programme: application of swabs as a paradigm for high throughput in a clinical setting. J Pers Med. 2023;13(7):1039.","journal-title":"J Pers Med"},{"key":"4483_CR12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.trac.2019.02.020","volume":"113","author":"IT Gug","year":"2019","unstructured":"Gug IT, Tertis M, Hosu O, Cristea C. Salivary biomarkers detection: analytical and immunological methods overview. TrAC Trends Anal Chem. 2019;113:301\u201316.","journal-title":"TrAC Trends Anal Chem"},{"issue":"3","key":"4483_CR13","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1053\/j.gastro.2009.11.010","volume":"138","author":"L Zhang","year":"2010","unstructured":"Zhang L, Farrell JJ, Zhou H, Elashoff D, Akin D, Park NH, et al. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. Gastroenterology. 2010;138(3):949-957. e947.","journal-title":"Gastroenterology"},{"issue":"1","key":"4483_CR14","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1053\/j.gastro.2022.03.054","volume":"163","author":"N Nagata","year":"2022","unstructured":"Nagata N, Nishijima S, Kojima Y, Hisada Y, Imbe K, Miyoshi-Akiyama T, et al. Metagenomic identification of microbial signatures predicting pancreatic cancer from a multinational study. Gastroenterology. 2022;163(1):222\u201338.","journal-title":"Gastroenterology"},{"issue":"12","key":"4483_CR15","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13848","volume":"52","author":"M Koopaie","year":"2022","unstructured":"Koopaie M, Kolahdooz S, Fatahzadeh M, Aleedawi ZA. Salivary noncoding RNA in the diagnosis of pancreatic cancer: systematic review and meta-analysis. Eur J Clin Invest. 2022;52(12):e13848.","journal-title":"Eur J Clin Invest"},{"key":"4483_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17091531","author":"\u00d3 Rapado-Gonz\u00e1lez","year":"2016","unstructured":"Rapado-Gonz\u00e1lez \u00d3, Majem B, Muinelo-Romay L, L\u00f3pez-L\u00f3pez R, Suarez-Cunqueiro MM. Cancer salivary biomarkers for tumours distant to the oral cavity. Int J Mol Sci. 2016. https:\/\/doi.org\/10.3390\/ijms17091531.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4483_CR17","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1007\/s10147-020-01660-7","volume":"25","author":"DX Assad","year":"2020","unstructured":"Assad DX, Mascarenhas ECP, de Lima CL, de Toledo IP, Chardin H, Combes A, et al. Salivary metabolites to detect patients with cancer: a systematic review. Int J Clin Oncol. 2020;25(6):1016\u201336.","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"4483_CR18","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10020043","volume":"10","author":"Y Asai","year":"2018","unstructured":"Asai Y, Itoi T, Sugimoto M, Sofuni A, Tsuchiya T, Tanaka R, et al. Elevated polyamines in saliva of pancreatic cancer. Cancers (Basel). 2018;10(2):43.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"4483_CR19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1186\/s12885-022-09570-9","volume":"22","author":"M Koopaie","year":"2022","unstructured":"Koopaie M, Ghafourian M, Manifar S, Younespour S, Davoudi M, Kolahdooz S, et al. Evaluation of CSTB and DMBT1 expression in saliva of gastric cancer patients and controls. BMC Cancer. 2022;22(1):473.","journal-title":"BMC Cancer"},{"issue":"5","key":"4483_CR20","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/cas.16112","volume":"115","author":"N Kajiwara","year":"2024","unstructured":"Kajiwara N, Kakihana M, Maeda J, Kaneko M, Ota S, Enomoto A, et al. Salivary metabolomic biomarkers for non-invasive lung cancer detection. Cancer Sci. 2024;115(5):1695\u2013705.","journal-title":"Cancer Sci"},{"issue":"2","key":"4483_CR21","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12020166","volume":"12","author":"LV Bel\u2019skaya","year":"2022","unstructured":"Bel\u2019skaya LV, Sarf EA, Solomatin DV, Kosenok VK. Metabolic features of saliva in breast cancer patients. Metabolites. 2022;12(2):166.","journal-title":"Metabolites"},{"key":"4483_CR22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.critrevonc.2016.12.009","volume":"110","author":"EC Porto-Mascarenhas","year":"2017","unstructured":"Porto-Mascarenhas EC, Assad DX, Chardin H, Gozal D, De Luca Canto G, Acevedo AC, et al. Salivary biomarkers in the diagnosis of breast cancer: a review. Crit Rev Oncol Hematol. 2017;110:62\u201373.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"4483_CR23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032998","volume":"24","author":"D Nose","year":"2023","unstructured":"Nose D, Sugimoto M, Muta T, Miura S-I. Salivary polyamines help detect high-risk patients with pancreatic cancer: a prospective validation study. Int J Mol Sci. 2023;24(3):2998.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4483_CR24","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14051139","volume":"14","author":"HA Adeola","year":"2022","unstructured":"Adeola HA, Bello IO, Aruleba RT, Francisco NM, Adekiya TA, Adefuye AO, et al. The practicality of the use of liquid biopsy in early diagnosis and treatment monitoring of oral cancer in resource-limited settings. Cancers (Basel). 2022;14(5):1139.","journal-title":"Cancers (Basel)"},{"key":"4483_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-024-02197-6","author":"R Devasahayam Arokia Balaya","year":"2024","unstructured":"Devasahayam Arokia Balaya R, Sen P, Grant CW, Zenka R, Sappani M, Lakshmanan J, et al. An integrative multi-omics analysis reveals a multi-analyte signature of pancreatic ductal adenocarcinoma in serum. J Gastroenterol. 2024. https:\/\/doi.org\/10.1007\/s00535-024-02197-6.","journal-title":"J Gastroenterol"},{"key":"4483_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2164-16-1","volume":"16","author":"M-S Kwon","year":"2015","unstructured":"Kwon M-S, Kim Y, Lee S, Namkung J, Yun T, Yi SG, et al. Integrative analysis of multi-omics data for identifying multi-markers for diagnosing pancreatic cancer. BMC Genomics. 2015;16:1\u201310.","journal-title":"BMC Genomics"},{"issue":"1","key":"4483_CR27","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s13046-024-03166-w","volume":"43","author":"K-L Reese","year":"2024","unstructured":"Reese K-L, Pantel K, Smit DJ. Multibiomarker panels in liquid biopsy for early detection of pancreatic cancer \u2013 a comprehensive review. J Exp Clin Cancer Res. 2024;43(1):250.","journal-title":"J Exp Clin Cancer Res"},{"key":"4483_CR28","volume":"156","author":"X Luo","year":"2020","unstructured":"Luo X, Liu J, Wang H, Lu H. Metabolomics identified new biomarkers for the precise diagnosis of pancreatic cancer and associated tissue metastasis. Pharmacol Res. 2020;156:104805.","journal-title":"Pharmacol Res"},{"key":"4483_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103332","author":"A El Kaoutari","year":"2021","unstructured":"El Kaoutari A, Fraunhoffer NA, Hoare O, Teyssedou C, Soubeyran P, Gayet O, et al. Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance. EBioMedicine. 2021. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103332.","journal-title":"EBioMedicine"},{"issue":"4","key":"4483_CR30","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13040498","volume":"13","author":"E Hyv\u00e4rinen","year":"2023","unstructured":"Hyv\u00e4rinen E, Kashyap B, Kullaa AM. Oral sources of salivary metabolites. Metabolites. 2023;13(4):498.","journal-title":"Metabolites"},{"issue":"1","key":"4483_CR31","volume":"8","author":"M You","year":"2023","unstructured":"You M, Xie Z, Zhang N, Zhang Y, Xiao D, Liu S, et al. Signaling pathways in cancer metabolism: mechanisms and therapeutic targets. Signal Transduct Target Ther. 2023;8(1):196.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"4483_CR32","volume":"2019","author":"R Vona","year":"2019","unstructured":"Vona R, Gambardella L, Cittadini C, Straface E, Pietraforte D. Biomarkers of oxidative stress in metabolic syndrome and associated diseases. Oxid Med Cell Longev. 2019;2019(1):8267234.","journal-title":"Oxid Med Cell Longev"},{"issue":"48","key":"4483_CR33","doi-asserted-by":"crossref","first-page":"7679","DOI":"10.3748\/wjg.v26.i48.7679","volume":"26","author":"A-L Wei","year":"2020","unstructured":"Wei A-L, Li M, Li G-Q, Wang X, Hu W-M, Li Z-L, et al. Oral microbiome and pancreatic cancer. World J Gastroenterol. 2020;26(48):7679.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4483_CR34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s40168-022-01262-7","volume":"10","author":"KM Herremans","year":"2022","unstructured":"Herremans KM, Riner AN, Cameron ME, McKinley KL, Triplett EW, Hughes SJ, et al. The oral microbiome, pancreatic cancer and human diversity in the age of precision medicine. Microbiome. 2022;10(1):93.","journal-title":"Microbiome"},{"key":"4483_CR35","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1007\/s12010-012-9891-5","volume":"168","author":"A Zhang","year":"2012","unstructured":"Zhang A, Sun H, Wang X. Saliva metabolomics opens door to biomarker discovery, disease diagnosis, and treatment. Appl Biochem Biotechnol. 2012;168:1718\u201327.","journal-title":"Appl Biochem Biotechnol"},{"issue":"6","key":"4483_CR36","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/biomedicines8060178","volume":"8","author":"C Tiffon","year":"2020","unstructured":"Tiffon C. Defining parallels between the salivary glands and pancreas to better understand pancreatic carcinogenesis. Biomedicines. 2020;8(6):178.","journal-title":"Biomedicines"},{"issue":"1","key":"4483_CR37","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12876-022-02443-2","volume":"22","author":"BV Stimec","year":"2022","unstructured":"Stimec BV, Ignjatovic D, Lobrinus JA. Establishing correlations between normal pancreatic and submandibular gland ducts. BMC Gastroenterol. 2022;22(1):362.","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"4483_CR38","doi-asserted-by":"crossref","DOI":"10.1016\/j.acthis.2022.151934","volume":"124","author":"B Theodory","year":"2022","unstructured":"Theodory B, Cao T, Swisher AR, Pham R, DiPatrizio NV, Yaghmour G. A novel approach to describing the pancreas and submandibular gland: can they be classified as primary and secondary tissue organs? Acta Histochem. 2022;124(6):151934.","journal-title":"Acta Histochem"},{"issue":"4","key":"4483_CR39","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1053\/j.gastro.2017.06.011","volume":"153","author":"M Zeng","year":"2017","unstructured":"Zeng M, Szymczak M, Ahuja M, Zheng C, Yin H, Swaim W, et al. Restoration of CFTR activity in ducts rescues acinar cell function and reduces inflammation in pancreatic and salivary glands of mice. Gastroenterology. 2017;153(4):1148\u201359.","journal-title":"Gastroenterology"},{"issue":"1","key":"4483_CR40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1152\/physrev.00011.2011","volume":"92","author":"MG Lee","year":"2012","unstructured":"Lee MG, Ohana E, Park HW, Yang D, Muallem S. Molecular mechanism of pancreatic and salivary gland fluid and HCO3 secretion. Physiol Rev. 2012;92(1):39\u201374.","journal-title":"Physiol Rev"},{"key":"4483_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8060178","author":"C Tiffon","year":"2020","unstructured":"Tiffon C. Defining parallels between the salivary glands and pancreas to better understand pancreatic carcinogenesis. Biomedicines. 2020. https:\/\/doi.org\/10.3390\/biomedicines8060178.","journal-title":"Biomedicines"},{"issue":"4","key":"4483_CR42","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jama.2017.19163","volume":"319","author":"MDF McInnes","year":"2018","unstructured":"McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM, the P-DTAG, et al. Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement. JAMA. 2018;319(4):388\u201396.","journal-title":"JAMA"},{"key":"4483_CR43","doi-asserted-by":"crossref","unstructured":"Deeks JJ, Bossuyt PM, Leeflang MM, Takwoingi Y, editors. Cochrane handbook for systematic reviews of diagnostic test accuracy. 1st edition. Chichester: John Wiley & Sons; 2023. https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook-systematic-reviews-diagnostic-test-accuracy.","DOI":"10.1002\/9781119756194"},{"key":"4483_CR44","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical research ed). 2021;372:n71.","journal-title":"BMJ (Clinical research ed)"},{"issue":"4","key":"4483_CR45","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/bimj.200410133","volume":"47","author":"NJ Perkins","year":"2005","unstructured":"Perkins NJ, Schisterman EF. The Youden Index and the optimal cut-point corrected for measurement error. Biom J. 2005;47(4):428\u201341.","journal-title":"Biom J"},{"issue":"8","key":"4483_CR46","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. Group Q-: QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529\u201336.","journal-title":"Ann Intern Med"},{"issue":"7414","key":"4483_CR47","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"issue":"1","key":"4483_CR48","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/jrsm.1439","volume":"12","author":"A Patel","year":"2021","unstructured":"Patel A, Cooper N, Freeman S, Sutton A. Graphical enhancements to summary receiver operating characteristic plots to facilitate the analysis and reporting of meta-analysis of diagnostic test accuracy data. Res Synth Methods. 2021;12(1):34\u201344.","journal-title":"Res Synth Methods"},{"issue":"1","key":"4483_CR49","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11306-009-0178-y","volume":"6","author":"M Sugimoto","year":"2010","unstructured":"Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics. 2010;6(1):78\u201395.","journal-title":"Metabolomics"},{"issue":"1","key":"4483_CR50","doi-asserted-by":"crossref","first-page":"12075","DOI":"10.1038\/s41598-018-30482-x","volume":"8","author":"A Tomita","year":"2018","unstructured":"Tomita A, Mori M, Hiwatari K, Yamaguchi E, Itoi T, Sunamura M, et al. Effect of storage conditions on salivary polyamines quantified via liquid chromatography-mass spectrometry. Sci Rep. 2018;8(1):12075.","journal-title":"Sci Rep"},{"key":"4483_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-78922-x","author":"O Deutsch","year":"2020","unstructured":"Deutsch O, Haviv Y, Krief G, Keshet N, Westreich R, Stemmer SM, et al. Possible proteomic biomarkers for the detection of pancreatic cancer in oral fluids. Sci Rep. 2020. https:\/\/doi.org\/10.1038\/s41598-020-78922-x.","journal-title":"Sci Rep"},{"key":"4483_CR52","doi-asserted-by":"publisher","unstructured":"Ruiz-Barrios LDR, Pineda-Razo TD, Hern\u00e1ndez-Flores G, Ortiz-Lazareno PC, Bravo-Cu\u00e9llar A, Macias-Lamas AM, Parra-Saavedra KJ, Palafox-Mariscal LA, Aguilar-Lemarroy A, Jave-Su\u00e1rez LF, et al. Expression of ornithine decarboxylase in peripheral blood mononuclear cells from patients with pancreatic adenocarcinoma: A preliminary report. Biomed Reports. 2024;20(3):38. https:\/\/doi.org\/10.3892\/br.2024.1726.","DOI":"10.3892\/br.2024.1726"},{"issue":"3","key":"4483_CR53","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1016\/j.ijid.2009.04.022","volume":"14","author":"DP Lima","year":"2010","unstructured":"Lima DP, Diniz DG, Moimaz SAS, Sumida DH, Okamoto AC. Saliva: reflection of the body. Int J Infect Dis. 2010;14(3):e184-8.","journal-title":"Int J Infect Dis"},{"issue":"4","key":"4483_CR54","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/gutjnl-2011-300784","volume":"61","author":"JJ Farrell","year":"2012","unstructured":"Farrell JJ, Zhang L, Zhou H, Chia D, Elashoff D, Akin D, et al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut. 2012;61(4):582\u20138.","journal-title":"Gut"},{"issue":"1","key":"4483_CR55","volume":"1879","author":"W Xu","year":"2024","unstructured":"Xu W, Liu J, Zhang J, Lu J, Guo J. Tumor microenvironment crosstalk between tumors and the nervous system in pancreatic cancer: molecular mechanisms and clinical perspectives. Biochim Biophys Acta Rev Cancer. 2024;1879(1):189032.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"5","key":"4483_CR56","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41388-020-01578-4","volume":"40","author":"X Tan","year":"2021","unstructured":"Tan X, Sivakumar S, Bednarsch J, Wiltberger G, Kather JN, Niehues J, et al. Nerve fibers in the tumor microenvironment in neurotropic cancer\u2014pancreatic cancer and cholangiocarcinoma. Oncogene. 2021;40(5):899\u2013908.","journal-title":"Oncogene"},{"issue":"24","key":"4483_CR57","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13246391","volume":"13","author":"SP Nakkina","year":"2021","unstructured":"Nakkina SP, Gitto SB, Pandey V, Parikh JG, Geerts D, Maurer HC, et al. Differential expression of polyamine pathways in human pancreatic tumor progression and effects of polyamine blockade on tumor microenvironment. Cancers (Basel). 2021;13(24):6391.","journal-title":"Cancers (Basel)"},{"key":"4483_CR58","doi-asserted-by":"crossref","first-page":"107327482110397","DOI":"10.1177\/10732748211039762","volume":"28","author":"SI Nissinen","year":"2021","unstructured":"Nissinen SI, Ven\u00e4l\u00e4inen M, Kumpulainen P, Roine A, H\u00e4kkinen MR, Veps\u00e4l\u00e4inen J, et al. Discrimination between pancreatic cancer, pancreatitis and healthy controls using urinary polyamine panel. Cancer Control. 2021;28:10732748211039762.","journal-title":"Cancer Control"},{"issue":"14","key":"4483_CR59","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25147623","volume":"25","author":"A Nicoletti","year":"2024","unstructured":"Nicoletti A, Paratore M, Vitale F, Negri M, Quero G, Esposto G, et al. Understanding the conundrum of pancreatic cancer in the omics sciences era. Int J Mol Sci. 2024;25(14):7623.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"4483_CR60","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/MEG.0000000000002415","volume":"34","author":"B Zhao","year":"2022","unstructured":"Zhao B, Zhao B, Chen F. Diagnostic value of serum carbohydrate antigen 19\u20139 in pancreatic cancer: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2022;34(9):891\u2013904.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"4483_CR61","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13643-019-1082-9","volume":"8","author":"B Duyx","year":"2019","unstructured":"Duyx B, Swaen GMH, Urlings MJE, Bouter LM, Zeegers MP. The strong focus on positive results in abstracts may cause bias in systematic reviews: a case study on abstract reporting bias. Syst Rev. 2019;8(1):174.","journal-title":"Syst Rev"},{"key":"4483_CR62","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jclinepi.2017.06.002","volume":"88","author":"B Duyx","year":"2017","unstructured":"Duyx B, Urlings MJE, Swaen GMH, Bouter LM, Zeegers MP. Scientific citations favor positive results: a systematic review and meta-analysis. J Clin Epidemiol. 2017;88:92\u2013101.","journal-title":"J Clin Epidemiol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04483-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04483-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04483-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:45:56Z","timestamp":1767627956000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-025-04483-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4483"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04483-w","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"10 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is a systematic review and meta-analysis that involved analysis of data from previously published studies. No new data were collected from human participants by the authors. All studies included in this review had obtained informed consent from their participants, as stated in their original publications.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}